abstract |
The present invention relates to antibodies against human transforming growth factor beta receptor II (TGFβRII), pharmaceutical compositions comprising said antibodies, and methods of using said antibodies, alone or in combination, for example, for the treatment of cancer and fibrosis. will be. |